Science Explorer Interactive view Map
Company · Osaka · Japan

AstraZeneca (Japan)

In research, AstraZeneca (Japan) stands highest in Medicine (#5,336 of 10,443 worldwide) and Health Sciences (#7,034 of 11,982 worldwide), 2022–2025.

astrazeneca.co.jpROR OpenAlex
World rank, 2022–2025
#13,133
of 28,054 · #15,622 all time
Rank in Japan
#341
of 1,070
Research works
317
▲ 302% vs 2013–17
Citations
9.7k
30.8 per fractional work
Top-10% rate
20.8%
record average 16.5%
Open access
52%
world 28%

What is AstraZeneca (Japan) known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #5,336 of 10,443 20.8%70 #8774
Health SciencesDomain #7,034 of 11,982 20.7%71 #11601

Each strip is that field’s whole ranked pool, with the notch where AstraZeneca (Japan) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.03× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.81× its world share, 15 worksBiochemistry, Geneti…Immunology and Microbiology: 4.06× its world share, 4 worksImmunology and Micro…Neuroscience: 0.15× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.22× its world share, 1 worksPharmacology, Toxico…Chemistry: 0.38× its world share, 1 worksChemistryComputer Science: 0.20× its world share, 2 worksComputer ScienceEngineering: 0.10× its world share, 2 worksEngineeringEnvironmental Science: 0.03× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.26× its world share, 1 worksMaterials ScienceMathematics: 0.54× its world share, 1 worksMathematicsPhysics and Astronomy: 0.06× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.49× its world share, 1 worksHealth ProfessionsMedicine: 3.57× its world share, 70 worksMedicineNursing: 0.30× its world share, 0 worksNursingBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Decision Sciences: 0.78× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 1.03× its world share, 2 worksEconomics, Econometr…Psychology: 0.08× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.1×. Every wedge is a field page.

Which keywords describe research at AstraZeneca (Japan)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Immunotherapy, Clinical Trials, Targeted Therapy, Treatment, Tumor Microenvironment, Inflammation and Diagnosis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Epidemiology9▲ 2.3×29 topics
  2. Chemotherapy9▲ 12×16 topics
  3. Immunotherapy8▲ 11×14 topics
  4. Inflammation8▲ 3.7×40 topics
  5. Treatment8▲ 6.1×15 topics
  6. Clinical Trials7▲ 11×10 topics
  7. Targeted Therapy7▲ 30×4 topics
  8. Diagnosis6▲ 6.2×13 topics
  9. Tumor Microenvironment6▲ 12×8 topics
  10. Genomic Profiling5▲ 50×2 topics
  11. Heart Failure4▲ 10×9 topics
  12. Lymphoma4▲ 28×3 topics
  13. Cancer4▲ 3.2×25 topics
  14. Cancer Immunotherapy4▲ 28×3 topics
  15. Management4▲ 5.2×8 topics
  16. Prognostic Factors4▲ 9.4×9 topics
  17. Cardiovascular Disease4▲ 3.6×16 topics
  18. Treatment Guidelines4▲ 19×4 topics
  19. Tumor Regression4▲ 34×2 topics
  20. ALK Inhibitors4▲ 60×1 topic
  21. Chronic Kidney Disease4▲ 15×7 topics
  22. EGFR Mutations4▲ 60×1 topic
  23. Asthma4▲ 37×2 topics
  24. Breast Cancer4▲ 15×6 topics
  25. CAR T Cells4▲ 50×1 topic
  26. Chimeric Antigen Receptor4▲ 50×1 topic
  27. Radiotherapy4▲ 9.5×6 topics
  28. Biomarkers4▲ 5.2×11 topics
  29. Genetics4▲ 4.9×6 topics
  30. Clinical Practice Guidelines3▲ 6.2×7 topics
  31. Precision Medicine3▲ 7.1×6 topics
  32. Adjuvant Therapy3▲ 24×2 topics
  33. Cancer Therapy3▲ 5.3×10 topics
  34. Rituximab3▲ 20×4 topics
  35. Immune Checkpoint Blockade3▲ 27×1 topic
  36. Immunology3▲ 28×2 topics
  37. PD-1 and PD-L13▲ 27×1 topic
  38. Allergic Diseases3▲ 48×1 topic
  39. Eosinophils3▲ 48×1 topic
  40. Molecular Characterization3▲ 16×4 topics

Which research topics does AstraZeneca (Japan) publish most on?

By volume in 2022–2025: Lung Cancer Treatments and Mutations, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Asthma and respiratory diseases.

Lung Cancer Treatments and Mutations: 4 fractional worksCAR-T cell therapy research: 4 fractional worksCancer Immunotherapy and…3Cancer Immunotherapy and Biomarkers: 3 fractional worksAsthma and respiratory d…3Asthma and respiratory diseases: 3 fractional worksChronic Lymphocytic Leukemia Research: 2 fractional worksLung Cancer Diagnosis and Treatment: 2 fractional worksChronic Obstructive Pulm…2Chronic Obstructive Pulmonary Disease (COPD) Research: 2 fractional worksPARP inhibition in cancer therapy: 2 fractional worksCancer Genomics and Diagnostics: 2 fractional worksRadiomics and Machine Learning in Medical Imaging: 2 fractional works
Pulmonary and Respiratory MedicineOncologyPhysiologyGenetics2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  2. 2 CAR-T cell therapy research Oncology 4 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 3 works
  4. 4 Asthma and respiratory diseases Physiology 3 works
  5. 5 Chronic Lymphocytic Leukemia Research Genetics 2 works
  6. 6 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
  7. 7 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 2 works
  8. 8 PARP inhibition in cancer therapy Oncology 2 works
  9. 9 Cancer Genomics and Diagnostics Cancer Research 2 works
  10. 10 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.7%not open48.3%

World: 28% of research is openly available.

with international co-authors79.5%domestic only20.5%

World: 19% is written across borders.

How has AstraZeneca (Japan)'s research output changed?

Output in 2018–2022 was 302% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Osaka

All research institutions in Osaka

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.